1. Home
  2. DDC vs OGEN Comparison

DDC vs OGEN Comparison

Compare DDC & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DDC
  • OGEN
  • Stock Information
  • Founded
  • DDC 2012
  • OGEN 1996
  • Country
  • DDC Hong Kong
  • OGEN United States
  • Employees
  • DDC N/A
  • OGEN N/A
  • Industry
  • DDC Metal Mining
  • OGEN Biotechnology: Pharmaceutical Preparations
  • Sector
  • DDC Basic Materials
  • OGEN Health Care
  • Exchange
  • DDC Nasdaq
  • OGEN Nasdaq
  • Market Cap
  • DDC 6.9M
  • OGEN 5.5M
  • IPO Year
  • DDC 2023
  • OGEN N/A
  • Fundamental
  • Price
  • DDC $0.17
  • OGEN $0.28
  • Analyst Decision
  • DDC Strong Buy
  • OGEN
  • Analyst Count
  • DDC 2
  • OGEN 0
  • Target Price
  • DDC $5.50
  • OGEN N/A
  • AVG Volume (30 Days)
  • DDC 873.4K
  • OGEN 950.8K
  • Earning Date
  • DDC 09-06-2017
  • OGEN 11-13-2024
  • Dividend Yield
  • DDC N/A
  • OGEN N/A
  • EPS Growth
  • DDC N/A
  • OGEN N/A
  • EPS
  • DDC N/A
  • OGEN N/A
  • Revenue
  • DDC $32,882,772.00
  • OGEN N/A
  • Revenue This Year
  • DDC N/A
  • OGEN N/A
  • Revenue Next Year
  • DDC N/A
  • OGEN N/A
  • P/E Ratio
  • DDC N/A
  • OGEN N/A
  • Revenue Growth
  • DDC 18.16
  • OGEN N/A
  • 52 Week Low
  • DDC $0.12
  • OGEN $0.25
  • 52 Week High
  • DDC $3.34
  • OGEN $5.27
  • Technical
  • Relative Strength Index (RSI)
  • DDC 45.91
  • OGEN 39.97
  • Support Level
  • DDC $0.15
  • OGEN $0.34
  • Resistance Level
  • DDC $0.20
  • OGEN $0.30
  • Average True Range (ATR)
  • DDC 0.03
  • OGEN 0.04
  • MACD
  • DDC 0.00
  • OGEN -0.01
  • Stochastic Oscillator
  • DDC 17.44
  • OGEN 8.41

About DDC DDC Enterprise Limited

DDC Enterprise Ltd is a content driven consumer brand offering easy, convenient ready-to-heat , ready-to-cook and plant-based meal products i.e. meal products consisting largely or solely of vegetables, fruits, grains and other foods derived from plant-based protein, rather than animal protein) while promoting healthier lifestyle choices to Millennial and Generation Z customer-base. It is also engaged in the provision of advertising services and the operation of experience stores to offer cooking classes.

About OGEN Oragenics Inc.

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.

Share on Social Networks: